Is genetic testing (BRCA1 / BRCA2 / HRD) necessary for all Triple-Negative Breast Cancer (TNBC) patients? Do sisters need screening?
I was recently diagnosed with Stage 2B Triple-Negative Breast Cancer at age 39. My oncologist advised NGS Next-Generation Sequencing panel for BRCA1/BRCA2. Is this mandatory? How will the genetic result change my surgery or chemo? Also I have two younger sisters aged 34 and 31 — do they need testing now?
Dr. B.K. Smruti (MBBS, MD, DNB (Medical Oncology))
Consultant Medical Oncologist, Lilavati Hospital, Mumbai
Yes, genetic testing is strongly recommended by both NCCN and ESMO clinical guidelines for any woman diagnosed with Triple-Negative Breast Cancer (TNBC) at or before age 60.
Here is why this test is critical for your personal treatment:
1. Surgical Choice: If you test positive for a pathogenic BRCA1/2 mutation, your risk of a second cancer in the other breast rises to ~40%. Many patients choose bilateral risk-reducing mastectomy with reconstruction instead of breast-conserving surgery.
2. Drug Selection: BRCA-positive tumors have defective DNA homologous repair. They are remarkably sensitive to platinum-based chemotherapy (Carboplatin) and targeted oral PARP inhibitors (such as Olaparib).
3. For your younger sisters: They should NOT be tested blindly. You (the diagnosed patient) must be tested first. If a specific genetic mutation is found in you, your sisters can then undergo simple single-site targeted cascade testing with formal genetic counseling.
Here is why this test is critical for your personal treatment:
1. Surgical Choice: If you test positive for a pathogenic BRCA1/2 mutation, your risk of a second cancer in the other breast rises to ~40%. Many patients choose bilateral risk-reducing mastectomy with reconstruction instead of breast-conserving surgery.
2. Drug Selection: BRCA-positive tumors have defective DNA homologous repair. They are remarkably sensitive to platinum-based chemotherapy (Carboplatin) and targeted oral PARP inhibitors (such as Olaparib).
3. For your younger sisters: They should NOT be tested blindly. You (the diagnosed patient) must be tested first. If a specific genetic mutation is found in you, your sisters can then undergo simple single-site targeted cascade testing with formal genetic counseling.
Medical guidance provided by registered oncologists. Does not substitute for an in-person physical clinical examination.